Bibliometric analysis of monoclonal antibodies for atherosclerosis

Jiqing Ma1, Kaiwen Zhao1, Yalin Zhu2,3

  • 1Department of Vascular Surgery, Changhai Hospital, Naval Medical University, Shanghai, China.

PubMed

Insights

This bibliometric study analyzes monoclonal antibodies (mAbs) for atherosclerosis (AS). Research shows inflammation and lipid metabolism are key areas, with the US leading global contributions in this evolving cardiovascular disease field.

Area of Science:

  • Cardiovascular Research
  • Immunotherapy
  • Bibliometrics

Background:

  • Atherosclerosis (AS) is a major cause of mortality in aging populations, posing a significant global healthcare burden.
  • The development of monoclonal antibodies (mAbs) for AS treatment is a rapidly expanding research area.

Conclusions:

  • Monoclonal antibody research for atherosclerosis is a dynamic field with significant ongoing advancements.
  • Current research directions emphasize inflammation and lipid metabolism, providing insights for future investigations.

Related Concept Videos